HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 215 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.66 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $11,953,369 | +34.7% | 228,292 | +4.6% | 0.00% | +50.0% |
| Q1 2024 | $8,874,666 | +6.0% | 218,158 | -3.7% | 0.00% | 0.0% |
| Q4 2023 | $8,369,962 | -7.1% | 226,460 | -4.0% | 0.00% | -33.3% |
| Q3 2023 | $9,011,573 | +2.9% | 235,905 | -2.9% | 0.00% | 0.0% |
| Q2 2023 | $8,759,490 | -19.5% | 242,847 | -14.8% | 0.00% | -25.0% |
| Q1 2023 | $10,880,063 | -19.7% | 284,893 | +19.6% | 0.00% | -20.0% |
| Q4 2022 | $13,555,290 | +44.1% | 238,230 | +0.1% | 0.01% | +25.0% |
| Q3 2022 | $9,409,000 | -21.4% | 237,959 | -12.6% | 0.00% | 0.0% |
| Q2 2022 | $11,973,000 | +2.9% | 272,125 | -6.7% | 0.00% | 0.0% |
| Q1 2022 | $11,636,000 | -2.0% | 291,756 | -1.2% | 0.00% | 0.0% |
| Q4 2021 | $11,876,000 | -1.0% | 295,353 | +0.2% | 0.00% | 0.0% |
| Q3 2021 | $11,991,000 | +2.2% | 294,767 | +14.1% | 0.00% | 0.0% |
| Q2 2021 | $11,729,000 | +27.1% | 258,298 | +16.7% | 0.00% | +33.3% |
| Q1 2021 | $9,226,000 | -2.7% | 221,294 | -0.3% | 0.00% | -25.0% |
| Q4 2020 | $9,479,000 | +229.1% | 221,958 | +102.6% | 0.00% | +300.0% |
| Q3 2020 | $2,880,000 | -11.7% | 109,569 | -9.9% | 0.00% | -50.0% |
| Q2 2020 | $3,261,000 | +77.6% | 121,656 | +19.0% | 0.00% | +100.0% |
| Q1 2020 | $1,836,000 | -9.1% | 102,245 | -10.2% | 0.00% | 0.0% |
| Q4 2019 | $2,019,000 | +42.2% | 113,822 | +24.2% | 0.00% | 0.0% |
| Q3 2019 | $1,420,000 | +19.6% | 91,624 | +32.6% | 0.00% | 0.0% |
| Q2 2019 | $1,187,000 | +34.3% | 69,093 | +25.8% | 0.00% | 0.0% |
| Q1 2019 | $884,000 | -12.1% | 54,941 | -20.0% | 0.00% | 0.0% |
| Q4 2018 | $1,006,000 | +0.7% | 68,707 | +25.0% | 0.00% | 0.0% |
| Q3 2018 | $999,000 | +38.0% | 54,981 | +28.1% | 0.00% | 0.0% |
| Q2 2018 | $724,000 | -17.6% | 42,937 | -4.3% | 0.00% | 0.0% |
| Q1 2018 | $879,000 | -27.1% | 44,878 | -24.3% | 0.00% | 0.0% |
| Q4 2017 | $1,205,000 | +15.3% | 59,289 | -1.4% | 0.00% | 0.0% |
| Q3 2017 | $1,045,000 | +84.3% | 60,157 | +36.4% | 0.00% | – |
| Q2 2017 | $567,000 | +13.6% | 44,116 | +14.5% | 0.00% | – |
| Q1 2017 | $499,000 | +29.3% | 38,531 | -1.2% | 0.00% | – |
| Q4 2016 | $386,000 | +21.4% | 39,011 | +46.0% | 0.00% | – |
| Q3 2016 | $318,000 | +37.1% | 26,714 | -2.3% | 0.00% | – |
| Q2 2016 | $232,000 | -11.1% | 27,332 | 0.0% | 0.00% | – |
| Q1 2016 | $261,000 | -31.1% | 27,332 | +24.6% | 0.00% | – |
| Q4 2015 | $379,000 | +37.3% | 21,940 | +6.1% | 0.00% | – |
| Q3 2015 | $276,000 | -39.5% | 20,683 | 0.0% | 0.00% | -100.0% |
| Q2 2015 | $456,000 | +55.6% | 20,683 | 0.0% | 0.00% | – |
| Q1 2015 | $293,000 | +91.5% | 20,683 | +30.5% | 0.00% | – |
| Q4 2014 | $153,000 | +4.1% | 15,853 | 0.0% | 0.00% | – |
| Q3 2014 | $147,000 | – | 15,853 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,816,162 | $195,784,000 | 9.33% |
| BB BIOTECH AG | 5,846,564 | $57,764,000 | 2.74% |
| QVT Financial LP | 4,556,090 | $45,014,000 | 2.44% |
| Parametrica Management Ltd | 29,578 | $292,000 | 2.21% |
| SECTORAL ASSET MANAGEMENT INC | 4,389,682 | $43,370,000 | 1.84% |
| Belmont Global Advisors, Inc. | 257,000 | $2,539,000 | 1.83% |
| HARVEY CAPITAL MANAGEMENT INC | 394,550 | $3,898,000 | 1.40% |
| Lombard Odier Asset Management (USA) Corp | 1,350,000 | $13,338,000 | 0.70% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 6,199,685 | $61,253,000 | 0.63% |
| Callan Capital, LLC | 199,230 | $1,968,000 | 0.53% |